share_log

Lumos Pharma | PRER14A: Preliminary revised proxy soliciting materials

SEC announcement ·  Feb 4, 2020 08:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more